Loading viewer...
conference
Format: PDF conference
Gilead Sciences presented at the 35th Annual J.P. Morgan Healthcare Conference in January 2017, detailing 2016 successes including launches of four new products (Descovy, Odefsey, Epclusa, and Vemlidy) and pipeline progress across HIV, HCV, HBV, and inflammatory disease programs. The presentation covers financial projections, risk factors, and clinical development timelines for investigational compounds.
earnings
38 Pages
conference
104 Pages
RunSignup
Lynas Rare Earths 2023 Diggers & Dealers Conference Presentation
conferenceconference
23 Pages
Lynas Rare Earths Limited